[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100530546":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":7,"responsibleParty":18,"collaborators":7,"id":22,"slug":23,"hasResults":24,"nctId":25,"briefTitle":26,"officialTitle":27,"acronym":7,"eligibilityCriteria":28,"healthyVolunteers":24,"sex":29,"minAge":30,"maxAge":31,"enrollmentInfo":32,"targetDuration":7,"studyType":35,"phases":7,"briefSummary":36,"conditions":37,"keywords":7,"overallStatus":39,"whyStopped":7,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Esraa Nageh","CONTACT","01012386384","esraanageh24434@gmail.com",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},"Yomna Refaat","01060178482","yomna-rm@hotmail.com",{"type":19,"investigatorFullName":20,"investigatorTitle":21,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Esraa Nageh Adam","Assistant Lecture","100530546","d-index-as-a-predictor-of-complication-of-treatment-of-patients-with-acute-myeloid-leukemia-100530546",false,"NCT06188182","D-index as a Predictor of Complication of Treatment of Patients With Acute Myeloid Leukemia","D-index as a Predictor of Complications of Febrile Neutropenia in Patients With Acute Myeloid Leukemia","Inclusion Criteria:\n\n1. Adult Patients (≥18 years) newly diagnosed as acute myeloid leukemia according to WHO 2016 diagnostic criteria.\n2. Hematologic diagnosis of de novo AML.\n3. Eastern Cooperative Oncology Group performance status (ECOG PS) 0-2.\n4. Standard induction chemotherapy (7+3 regimen) or consolidation regimens (HiDAC).\n\nExclusion Criteria:\n\n1\\) AML on top of other hematological disorders. 2) Acute promyelocytic leukemia. 3) Patients who received palliative care or low-intensity treatment. 4) Poor PS (≥3) at the time of diagnosis.\n\n\\-","ALL","18 Years","70 Years",{"count":33,"type":34},60,"ESTIMATED","OBSERVATIONAL","1. The effect of D-index on the onset and severity of FN in AML patients.\n2. Relationship between the c-D-index and duration of FN in AML patients.\n3. Correlation between D-index and MDR.\n4. Correlation between D-index and invasive fungal infection.\n5. Comparison of FN in different treatment protocols for AML using D-index.\n6. Prediction of pulmonary, fungal or blood stream infection.",[38],"AML, Adult","NOT_YET_RECRUITING","2024-01-01",{"date":42,"type":43},"2024-01-03","ACTUAL",{"date":45,"type":34},"2024-06-01",{"date":47,"type":34},"2026-06",{"name":5,"class":6}]